TG THERAPEUTICS, INC. Class of Warrant or Right, Outstanding
TG THERAPEUTICS, INC. (TGTX) had Class of Warrant or Right, Outstanding of 147.06 thousand shares as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2021-03-01
- 2020-12-31: Class of Warrant or Right, Outstanding 147.06K shares.
- 2019-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2017-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2020-12-31 | 147.06K shares 10-K · filed 2021-03-01 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2020-03-02 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-02 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2020-03-02 | |
| 2016-12-31 | 913.38K shares 10-K · filed 2019-03-01 | 876.91K shares 10-K · filed 2017-03-16 |
| 2015-12-31 | 1.19M shares 10-K · filed 2019-03-01 | |
| 2015-09-30 | 1.21M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 1.22M shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 3.96M shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 4.15M shares 10-K · filed 2018-03-15 | |
| 2014-09-30 | 4.44M shares 10-Q · filed 2014-11-14 | |
| 2014-06-30 | 5.01M shares 10-Q · filed 2014-07-24 | |
| 2014-03-31 | 5.31M shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | 5.72M shares 10-K · filed 2017-03-16 | |
| 2013-09-30 | 5.89M shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 6.01M shares 10-Q · filed 2013-08-09 | |
| 2013-03-31 | 6.36M shares 10-Q · filed 2013-05-14 | |
| 2012-12-31 | 6.78M shares 10-K · filed 2016-03-15 | |
| 2012-09-30 | 4.28M shares 10-Q · filed 2012-11-14 | |
| 2012-06-30 | 4.28M shares 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | 1.63M shares 10-K · filed 2014-03-07 | 2.12M shares 10-Q/A · filed 2012-09-07 |
| 2010-12-31 | 0.00 shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |